celastrol has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JY; Dai, LY; Li, ZJ; Liu, JH; Luo, P; Tian, Y; Wang, JG; Yang, F; Zhang, JZ; Zhang, Q; Zheng, LH; Zhong, TY; Zou, C | 1 |
| Jin, H; Sun, K; Xing, Y; Yu, F; Zhao, W; Zheng, X | 1 |
2 other study(ies) available for celastrol and Sepsis
| Article | Year |
|---|---|
Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Endotoxemia; HMGB1 Protein; Humans; Inflammation; Lipopolysaccharides; Mice; Pentacyclic Triterpenes; Pyruvate Kinase; Sepsis | 2022 |
Combination Therapy with Resveratrol and Celastrol Using Folic Acid-Functionalized Exosomes Enhances the Therapeutic Efficacy of Sepsis.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Exosomes; Folic Acid; Lipopolysaccharides; Mice; Pentacyclic Triterpenes; Resveratrol; Sepsis | 2023 |